List of bibliographic references indexed by immunogenicity
Number of relevant bibliographic references: 7.
Ident. | Authors (with country if any) | Title |
---|
000021 (2019) |
Micha Loebermann [Allemagne] ; Carlos Fritzsche [Allemagne] ; Hilte Geerdes-Fenge [Allemagne] ; Esther Heijnen [Pays-Bas] ; Daniel Kirby [États-Unis] ; Emil C. Reisinger [Allemagne] | A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults. |
000040 (2018) |
Roman Prymula [République tchèque] ; Dorothee Kieninger [Allemagne] ; Emmanuel Feroldi [France] ; Emilia Jordanov [États-Unis] ; Siham B'Chir [France] ; Xavier Dacosta [États-Unis] | Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic. |
000092 (2016) |
Jakob P. Cramer [Allemagne] ; Katrin Dubischar [Autriche] ; Susanne Eder [Autriche] ; Gerd D. Burchard [Allemagne] ; Tomas Jelinek [Allemagne] ; Bernd Jilma [Autriche] ; Herwig Kollaritsch [Autriche] ; Emil Reisinger [Allemagne] ; Kerstin Westritschnig [Autriche] | Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. |
000205 (2013) |
Ulrich Zimmermann [Allemagne] ; Gaëtan Gavazzi ; Patrick Richard ; Cécile Eymin ; Benoît Soubeyrand ; Martine Baudin | Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial. |
000229 (2012) |
Mathieu Peeters [Belgique] ; Stefan Regner ; Tejaswini Vaman ; Jeanne-Marie Devaster ; Lars Rombo | Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials. |
000245 (2012) |
Cynthia Nassim [États-Unis] ; Shane Christensen ; Dan Henry ; Sandra Holmes ; Matthew Hohenboken ; Niranjan Kanesa-Thasan | Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age. |
000292 (2011) |
J. Garcia-Sicilia [Espagne] ; P. Gillard ; A. Carmona ; J C Tejedor ; J. Aristegui ; J M Merino ; U. Behre ; A. Caplanusi ; T. Vaman ; I. Dieussaert | Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "immunogenicity"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "immunogenicity" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeAllemagneV3
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= immunogenicity
}}
| This area was generated with Dilib version V0.6.35. Data generation: Tue Jul 7 11:47:10 2020. Site generation: Sat Sep 26 09:55:33 2020 | |